NuVasive Investor Relations

NuVasive is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes.

Analyst Coverage

Firm Analyst
Aegis Capital Corp
Jason Wittes
Bank of America / Merrill Lynch
Bob Hopkins
Barclays Capital
Matt Taylor
BGIT
Ryan Zimmerman
BMO Capital Markets
Joanne Wuensch
Canaccord Genuity
Kyle Rose
Cowen
Josh Jennings
Gabelli & Company
Jennie Tsai
Jefferies & Company, Inc.
Raj Denhoy
JMP Securities
David Turkaly
JPMorgan
Robbie Marcus
Leerink Partners
Richard Newitter
Morgan Stanley
Jon Demchick
Needham and Company
Mike Matson
Piper Jaffray
Matthew O’Brien
RBC Capital Markets
Glenn Novarro
Robert W. Baird & Co.
Jeff D. Johnson
Wells Fargo Securities
Shagun Singh
William Blair & Company
Kaila Krum

Nuvasive Inc is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Nuvasive Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Nuvasive Inc or its management. Nuvasive Inc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.